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Low Caveolin-1 Expression Contributes to
Idiopathic Pulmonary Fibrosis
Low PTEN levels have been implicated in the overprolif-
eration of fibroblasts following tissue injury. However, the
molecular mechanisms underlying the low expression of
PTEN in lung fibroblasts in idiopathic pulmonary fibrosis
(IPF) remain to be determined. Xia et al (Am J Pathol
2010, 176:2626–2637) hypothesized that caveolin-1,
which is decreased in fibroblasts in IPF patients, may be
responsible for the levels of PTEN expression in these
cells. They correlated low levels of caveolin-1 and PTEN
expression and demonstrated that overexpression of
caveolin-1 restored PTEN expression in IPF fibroblasts. In-
deed, PTEN interacted with caveolin-1 through its caveolin-
1-binding sequence. Decreased caveolin-1 expression
therefore facilitates the overproliferation of fibroblasts in IPF.
Antigen-Specific Regulatory Cells Block the
Development of Autoimmunity
Antigen-specific effector CD4 T cells that produce inter-
leukin-17 (Th17 cells) are believed to initiate the inflamma-
tory process in experimental autoimmune encephalitis
(EAE), a mouse model of multiple sclerosis. As interferon
(IFN)- suppresses Th17 cell development, Wildbaum et al
(Am J Pathol 2010, 176:2764–2775) hypothesized that
IFN- expressing CD4 T cells may serve as regulatory
cells to block the development of autoimmunity. They dis-
covered that EAE development depended on FasL-medi-
ated apoptosis of these antigen-specific IFN--expressing
regulatory cells at early stages of disease and that inhibiting
FasL signaling at early stages of EAE suppressed disease
development. In addition, overexpression of IFN- in EAE-
mediating T cells caused them to act instead as antigen-
specific regulatory cells. Thus, early suppression of Th17
cells may block the development of autoimmunity.
New Model for Chronic Wasting Disease
Chronic wasting disease is a fatal prion-induced disease
that affects cervids such as deer, elk, and moose. Using a
mouse model of chronic wasting disease that expresses
cervid prion protein (PrP), Seelig et al (Am J Pathol 2010,
176:2785–2797) examined the susceptibility, pathogenesis,
and transmission of cervid chronic wasting disease. In this
model they found that cervid PrPC (protease-sensitive PrP)
was expressed in lymphoid, nervous, hematopoietic, endo-
crine, and certain epithelial tissues in this model. Addition-
ally, induced spongiform encephalopathy could be trans-
ferred by intracerebral, intravenous, intraperitoneal, and
oral routes, although the oral route required a larger infect-
ing dose. Furthermore, this disease could be transferred
horizontally without experimental intervention to uninfected
mice, highlighting the suitability of this system in studying
cervid transmissible spongiform encephalopathy.
Inflammasome Increases Muscle Damage in
Muscular Dystrophy
Many patients with muscular dystrophy show signs of in-
flammation; however, the mechanisms governing this in-
flammation in disease pathogenesis remain unexplored. To
investigate the role of the inflammasome in muscular dys-
trophy, Rawat et al (Am J Pathol 2010, 176:2891–2900)
examined the inflammasome platform in mouse and human
dysferlin-deficient tissues, which develop limb girdle mus-
cular dystrophy type 2B. They found that components of the
NALP-3 inflammasome pathway were up-regulated and ac-
tivated in dysferlin-deficient muscle as compared with con-
trol muscle and that primary skeletal muscle cells can
secrete interleukin-1, directly participating in inflam-
masome formation. Moreover, dysferlin-deficient muscle
cells expressed the innate immune molecules Toll-like re-
ceptor-2 and -4, suggesting that affected muscle may di-
rectly contribute to inflammation in muscular dystrophy and
providing a new therapeutic target for limb girdle muscu-
lar dystrophy type 2B.
New Target May Inhibit Metastatic Breast
Cancer
The pro-apoptotic protein galectin-7 is expressed in and
plays a metastatic role in various types of cancer. To
determine the role of galectin-7 in breast cancer, Demers
et al (Am J Pathol 2010, 176:3023–3031) investigated
galectin-7 expression and function in these cells. Galec-
tin-7 was highly expressed in two pre-clinical models of
breast cancer, and high galectin-7 expression levels in-
creased the metastatic potential of these tumor cells. In
humans, high expression levels of galectin-7 were re-
stricted to high-grade tumors and were associated with
metastasis. Taken together, these data implicate galec-
tin-7 as both a breast cancer differentiation marker and a
potential therapeutic target for metastatic breast cancer.
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